Abstract
Matrix rigidity has important effects on cell behavior and is increased during liver fibrosis; however, its effect on primary hepatocyte function is unknown. We hypothesized that increased matrix rigidity in fibrotic livers would activate mechanotransduction in hepatocytes and lead to inhibition of hepatic-specific functions. To determine the physiologically relevant ranges of matrix stiffness at the cellular level, we performed detailed atomic force microscopy analysis across liver lobules from normal and fibrotic livers. We determined that normal liver matrix stiffness was around 150Pa and increased to 1-6kPa in areas near fibrillar collagen deposition in fibrotic livers. In vitro culture of primary hepatocytes on collagen matrix of tunable rigidity demonstrated that fibrotic levels of matrix stiffness had profound effects on cytoskeletal tension and significantly inhibited hepatocyte-specific functions. Normal liver stiffness maintained functional gene regulation by hepatocyte nuclear factor 4 alpha (HNF4α) whereas fibrotic matrix stiffness inhibited the HNF4α transcriptional network. Fibrotic levels of matrix stiffness activated mechanotransduction in primary hepatocytes through focal adhesion kinase (FAK). In addition, blockade of the Rho/Rho-associated protein kinase (ROCK) pathway rescued HNF4α expression from hepatocytes cultured on stiff matrix. Conclusion: Fibrotic levels of matrix stiffness significantly inhibit hepatocyte-specific functions in part by inhibiting the HNF4α transcriptional network mediated through the Rho/ROCK pathway. Increased appreciation of the role of matrix rigidity in modulating hepatocyte function will advance our understanding of the mechanisms of hepatocyte dysfunction in liver cirrhosis and spur development of novel treatments for chronic liver disease.
It is increasingly evident that the rigidity of extracellular matrix has a profound effect on cell behavior, including cell function, proliferation, and motility (1, 2) . The response of epithelial cells to matrix stiffness is mediated by an intricate mechanotransduction cascade in which cells sense the mechanical signals in their environment and activate intracellular signaling pathways.
These pathways involve integrin clustering and activation of focal adhesion kinase (FAK), the Rho/Rho-associated protein kinase (ROCK) pathway, and the extracellular signal-regulated kinase (ERK) pathway (3) (4) (5) . While these fundamental mechanosensing mechanisms are likely generalizable, how they uniquely regulate the cellular function of hepatocytes, a highly specialized epithelial cell, is unknown.
In the liver, fibrosis, and ultimately cirrhosis, is the final common pathway of chronic liver diseases due to a variety of causes that span viral infections (hepatitis B and C), chemical insults (e.g. alcohol), inflammatory conditions (non-alcoholic steatohepatitis, autoimmune hepatitis), and metabolic dyscrasias (alpha-1 antitrypsin deficiency, hemochromatosis, Wilson's disease, etc.). The degree of liver fibrosis in humans has been shown to correlate well with liver tissue stiffness as determined by non-invasive diagnostic methods such as ultrasound-based transient and shear-wave elastography (6) and magnetic resonance elastography (7, 8) . The significance of matrix rigidity in liver fibrosis has been established by experiments demonstrating that increased matrix stiffness was required to activate stellate cells and portal fibroblasts, the key cell types responsible for abnormal extracellular matrix deposition in the fibrogenic process (9, 10) . In addition, hepatocellular carcinomas, the majority of which arise in the setting of liver fibrosis, show increased proliferation and resistance to chemotherapeutic agents when cultured on matrix with greater rigidity (11) .
What remains unknown about the effect of increased matrix stiffness during the course of liver fibrosis is how it may alter the function of primary hepatocytes. This is an important question because the cause of liver failure in cirrhosis is not fully understood and there is evidence that hepatocytes removed from a cirrhotic microenvironment may regain lost function when replaced into a non-cirrhotic host liver (12) . We hypothesize that increased matrix rigidity directly inhibits hepatic-specific functions and is a major mechanism of liver dysfunction in the setting of advanced liver fibrosis. There is mounting evidence that the process of liver fibrosis may be reversed by elimination of the injurious agent(s) and, potentially, by targeted anti-fibrotic therapies (13) . If changes in matrix stiffness directly modulate primary hepatocyte functions, then such changes may be a likely mechanism to explain how liver function improves as fibrosis resolves. If proven, this mechanism would also provide a rationale for developing therapies that intercept the mechanotransduction signal cascade in primary hepatocytes in the setting of advanced cirrhosis with the goal of preserving liver function.
A major barrier to investigating the physiologically relevant effects of matrix stiffness on hepatocyte function is that normal versus pathological levels of matrix rigidity have not been fully defined at the cellular level. Transient and shear-wave elastography, expressing stiffness in elastic modulus (E), estimated normal human liver stiffness to be around 5kPa and grade 4 cirrhotic livers to be . Magnetic resonance elastography, expressing stiffness in shear modulus (G'), determined normal human liver stiffness to be 2kPa and placed the matrix stiffness cutoff for grade 4 cirrhotic livers at >5kPa (7, 8) . For all these non-invasive technologies, liver stiffness values are extrapolated from the response of tissues to generated shear waves and may not accurately reflect mechanical tissue stiffness. Mechanical measurements of bulk liver tissue from humans and rodents by rheometry suggest that true liver stiffness is likely much softer, ranging between 400-600Pa for normal liver and 1.2-1.6kPa for fibrotic liver (14, 15) . Liver fibrosis, however, is not a homogenous process at the tissue level and bulk tissue measurements at best represent an average of what individual hepatocytes encounter at a cellular level. Even in cases of advanced fibrosis where there are bridging fibrotic bands, areas of relatively less collagen deposition remain, suggesting that changes in matrix rigidity may be specific to the local microenvironment.
Therefore, in order to determine whether physiologically relevant levels of matrix rigidity may modulate primary hepatocyte function, we first performed detailed microscale analyses across liver lobules using atomic force microscopy (AFM) to define the normal and pathological ranges of matrix stiffness that hepatocytes encounter within the liver. We then isolated primary hepatocytes from mice and cultured them on collagen matrices with tunable rigidity to determine the effect of these levels of matrix stiffness on hepatocyte function and mechanotransduction.
Material and Methods

Atomic Force Microscopy (AFM).
Measurement s on fresh liver tissues were carried out on samples embedded in 4% low melting point agarose and cut into 50 µm sections using a Leica VT1000S vibratome (Buffalo Grove, IL). Measurements on frozen liver tissues were performed on livers embedded in OCT compound (Sakura, Torrance, CA), snap frozen via direct immersion into liquid nitrogen, and cut into 50μm sections on a Leica CM1900-13 cryostat. During AFM analysis, samples were maintained in protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN) and propidium iodide (Sigma). Similar to methods previously described (16), measurements were conducted using a MFP3D-BIO inverted optical AFM (Asylum Research, Santa Barbara, CA) mounted on a Nikon TE200-U inverted fluorescence microscope (Melville, NY). Silicon nitride cantilevers (k = 0.06 N/m) modified with a 5µm diameter borosilicate glass spherical tip (Novascan Tech, Ames, IA) were used for indentation. For each session, cantilevers were calibrated using the thermal oscillation method. AFM force maps were performed on 90µm×90µm fields. Gradients were generated post-acquisition. Each experimental group included at least 3 different mice, with 3 sections from each mouse, and 2 gradients (one orthogonal and one parallel to the fibrosis) generated per section. Data analyses were done using the Hertz model in Igor Pro v. 6.22A (WaveMetrics, Lake Oswego, OR) and a
Poisson's ratio of 0.5. Laramie, WY). Rat-tail collagen I (VWR, Brisbane, CA) was then added to the surface at 150ug/mL to allow coupling to the gel through side-chain primary amines.
Primary
Please refer to Supplemental Methods for additional methodological details. To determine normal liver matrix stiffness at the cellular level, AFM was used to obtain detailed measurements across liver lobules from untreated wild-type mice. We initially performed our AFM studies on fresh liver tissue and subsequently switched to frozen tissue after confirming that there were no differences in tissue extracellular matrix stiffness between the two conditions (Supplemental Figure 1A ). Measurements were carried out spanning from periportal zones to pericentral zones as well as from periportal zones to adjacent periportal zones. We found that matrix rigidity ranged consistently around 150Pa in normal livers with minimal variation from portal to central zones or portal to portal zones ( Figure 2B ). When stiffness measurements in pericentral and periportal zones were extracted and directly compared with each other, we found that matrix stiffness in periportal zones had slightly greater variability and trended slightly higher compared to pericentral zones (Supplemental Figure 1B) , potentially reflecting the fact that portal tracts normally have more extracellular matrix than areas around central veins.
Results
Normal
Because patterns of fibrosis differed depending on the model of experimental fibrotic disease, we conducted a series of AFM measurements orthogonal to the fibrotic tract or along the fibrotic tract within a lobule (see diagram in Figure 2A ). This analysis revealed that increased matrix stiffness within fibrotic livers was localized to the microenvironments around fibrotic tracts.
Measurements orthogonal to fibrotic tracts showed that liver matrix was significantly stiffer in regions approaching fibrillar collagen deposition and returned to near normal rigidity in areas remote from it within the same lobule ( Figure 2C ). Although, in a few instances, non-fibrotic areas of CCl 4 -and DDC-treated livers showed a trend toward slightly greater matrix stiffness than normal livers, there were no statistically significant differences when considered in aggregate (Supplemental Figure 1C ). Matrix stiffness was significantly greater in severe forms of CCl 4 -or DDC-induced disease compared to their respective mild forms, but only in areas with or near fibrotic tracts. Along the fibrotic tracts, the average matrix stiffness was around 1kPa in CCl 4 -treated mice and ranged 2-3kPa in DDC-treated mice, both significantly greater than the stiffness across a normal liver lobule ( Figure 2D ). There were also statistically significant increases in stiffness along fibrotic tracts in severe CCl 4 -or DDC-induced disease compared to mild disease, suggesting that the rigidity of fibrotic tracts increased as disease progressed. In general, fibrotic tracts in DDC-induced disease were stiffer than in CCl 4 -induced disease, peaking near 6kPa in the former compared to 2kPa in the latter. These results demonstrated that matrix stiffness was significantly increased along or near fibrotic tracts compared to normal liver tissue. Importantly, matrix rigidity was highly region-specific and varied between local microenvironments within fibrotic livers depending on the proximity to fibrotic tracts and the disease model.
Matrix stiffness has significant effects on primary hepatocyte cytoskeletal tension and function. Isolated primary hepatocytes were cultured on top of collagen-conjugated polyacrylamide gels ranging in stiffness from below physiologic (75Pa) to highly supraphysiologic levels (60kPa) to determine the effect on cell spreading. Increased cell spreading, as determined by increased cell area, indicated greater cytoskeletal tension (19) . We found that primary hepatocyte cell area, and therefore cytoskeletal tension, increased logarithmically with increasing matrix stiffness ( Figure 3A) . As demonstrated on a linear graph ( Figure 3A inset), hepatocytes responded to increasing matrix stiffness most dynamically at the lower ranges of rigidity between 75Pa and 1kPa. Interestingly, 1kPa was the lower limit within the range of pathological matrix stiffnesses detected in fibrotic livers near fibrotic tracts. At stiffnesses greater than 1kPa, hepatocyte cell size continued to increase but at a more gradual rate.
Representative photos of hepatocytes on the collagen-PA gels demonstrated that at 140Pa, the matrix stiffness of normal liver, cells were rounded and their nuclei were obscured by the spherical contour of the cell ( Figure 3B ). As matrix stiffness increased to 1kPa, hepatocytes flattened and became spread so that their nuclei were more visible. Cell spreading and flattening continued to increase from 1kPa to 6kPa, the upper limit of pathological liver matrix rigidity in fibrotic livers. At the supra-physiological stiffness of 60kPa, hepatocytes had spread and flattened even more compared to 6kPa, although the change in cell area and morphology was less dramatic than at lower ranges of matrix stiffness. In summary, these results showed that physiological and pathological ranges of matrix stiffness had profound effects on hepatocyte cell morphology and cytoskeletal tension.
To determine whether changes in hepatocyte morphology in response to matrix stiffness were associated with changes in function, we quantitatively measured albumin production, glycogen storage, and cytochrome P450 activity from isolated primary hepatocytes cultured on top of collagen-PA gels of varying stiffness ( Figure 4A -C). We found that albumin production from hepatocytes cultured on top of stiffer matrix decreased significantly compared to those cultured on the physiologically normal stiffness of 140Pa. Interestingly, there appeared to be a threshold effect in which albumin production significantly decreased from 140Pa to 1kPa, with no further significant decreases detected at matrix stiffnesses greater than 1kPa compared to 1kPa. There was a trend toward decreased hepatocyte glycogen storage ability with increasing matrix stiffness. Intrinsic cytochrome P450 1A activity was low in hepatocytes plated on top of collagen-PA gels and not significantly affected by matrix rigidity. Hepatocyte proliferation increased on stiff compared to soft matrix and may reflect activation of aberrant proliferative signal transduction pathways (Supplemental Figure 2) . These findings indicated that, in conjunction with changes in cytoskeletal tension, increasing matrix stiffness significantly inhibited albumin production and may also adversely affect other hepatocyte-specific functions.
Fibrotic ranges of matrix stiffness decreased the expression of functional genes within the hepatocyte nuclear factor 4 alpha (HNF4α) regulatory network. We previously demonstrated that HNF4α was a key regulator for maintaining hepatocyte-specific functions in threedimensional (3D) culture compared to two-dimensional (2D) monolayer culture (20) . Since difference in substrate rigidity was one facet of the differences between 3D and 2D physical environments, we hypothesized that HNF4α and its downstream targets may be modulated by matrix rigidity. We co-stained liver tissue from untreated, CCl 4 -, and DDC-treated mice for
HNF4α and fibronectin and found that the percentage of HNF4α positive cells was significantly decreased in fibrotic compared to normal livers ( Figure 5A and B). Indeed, expression of Hnf4a itself and 3 important transcriptional functional targets (Baat, bile acid-CoA:amino acid Nacyltransferase; F7, factor VII; Gys2, glycogen synthase 2), was significantly decreased in hepatocytes cultured on stiffer matrices compared to normal liver matrix stiffness ( Figure 5C ).
Similarly to the effect of increasing stiffness on albumin production, there was a threshold effect at the pathological stiffness level of 1kPa, at which there was a significant decrease in the expression of these functional genes. These findings indicated that pathological levels of liver matrix rigidity suppressed the expression of HNF4α and consequently the expression of several of its downstream functional targets.
To clarify the interaction between matrix rigidity and the HNF4α transcriptional regulatory network, we isolated primary hepatocytes from Hnf4a . We cultured wild-type and HNF4α-deficient hepatocytes on collagen-PA gels of normal liver matrix stiffness (140Pa) to determine whether softer matrix maintained expression of certain functional genes through the maintained expression of HNF4α. We found that expression of the functional genes Baat, F7, and Gys2 was significantly decreased in HNF4α-deficient compared to wild-type hepatocytes on 140Pa matrix, indicating that maintained expression of HNF4α was critical for the expression of these genes on matrix of normal liver stiffness ( Figure 6A ). Conversely, HNF4α has been shown to actively suppress the transcription of mesenchymal genes such as Snail (Snai1) and vimentin (Vim) in hepatocytes (21); these genes were significantly increased in HNF4α-deficient compared to wild-type hepatocytes on 140Pa matrix. These results suggest that normal soft matrix supported hepatocyte-specific functions in part by maintaining the HNF4α transcriptional regulatory network, while pathological stiff matrix inhibited hepatocyte function because HNF4α expression was lost.
We then determined whether forced expression of HNF4α in hepatocytes cultured on stiff matrix was sufficient to restore expression of hepatic functional genes. We transfected primary hepatocytes plated on 1kPa matrix with either a control plasmid or plasmid expressing mouse HNF4α under the cytomegalovirus promoter. HNF4α plasmid transfection was able to achieve high over-expression of Hnf4a (>85-fold) compared to control plasmid. These findings suggest that HNF4α is necessary for the maintenance of hepatic functional genes on soft matrix, but not sufficient on its own to restore hepatic functional gene expression on stiff matrix. These results also suggest that increased matrix rigidity has other negative effects on the regulation of normal hepatocyte function in addition to the inhibition of HNF4α expression. In addition, we performed phospho-FAK Y397 / HNF4α and activated β1-integrin/ HNF4α costaining to confirm that activation of the integrin-FAK pathway was taking place in hepatocytes.
We found that hepatocytes near fibrotic tracts, and corresponding to areas of high matrix rigidity, showed significant expression of activated phospho-FAK Y397 ( Figure 7A ). Interestingly, phospho-FAK Y397 expression in hepatocytes was both membranous and cytoplasmic in livers from DDC-treated mice, whereas it was restricted to the membrane in hepatocytes of CCl 4 -treated mice. Activated β1-integrin was demonstrated on hepatocyte membranes in the livers of both CCl 4 -and DDC-treated mice, with higher levels of positive staining observed in DDCtreated mice. These findings showed that the mechanotransduction pathway through integrin and FAK was activated in hepatocytes near fibrotic tracts in vivo in fibrotic liver disease.
To determine whether activation of FAK in hepatocytes near fibrotic tracts was attributable to increased matrix stiffness, we cultured isolated primary hepatocytes on collagen-PA matrices and quantified the level of phospho-FAK Y397 by immunoblotting. We found that phospho-FAK Y397 was significantly increased in hepatocytes cultured on fibrotic (1kPa) and supra-physiological (60kPa) levels of matrix rigidity compared to normal liver stiffness (140Pa) ( Figure 7B ).
Interestingly, a threshold phenomenon similar to albumin production and functional gene expression was observed. Phospho-FAK Y397 was significantly greater in hepatocytes cultured on 1kPa compared to 140Pa and further increases in FAK activation were minimal between 1kPa and 60kPa. These results indicated that fibrotic levels of matrix rigidity at 1kPa were sufficient to activate FAK in primary hepatocytes. 
Matrix rigidity modulated HNF4α expression in primary hepatocytes
Discussion
Our study is the first to fully define the normal and pathological ranges of liver matrix rigidity on the cellular level across the microanatomical architecture of the liver lobule. Our results are also the first to show that matrix rigidity, as an isolated variable, is sufficient to modulate primary hepatocyte function through the effects of the Rho/ROCK pathway on the HNF4α transcriptional network. Previous studies have shown that changes in matrix composition (22) , ligand density (23, 24) , structure (25, 26) , and cross-linking (27) altered hepatocyte function, proliferation, and response to growth factors. Dedifferentiation and redifferentiation of hepatocytes by altering matrix conformation correlated with HNF4α expression levels (28, 29) . Although changes in those matrix variables also changed the substrate rigidity, those studies could not definitively determine whether matrix stiffness was primarily responsible for the observed effects. By culturing primary hepatocytes on collagen matrices of tunable rigidity, we showed that increased matrix stiffness in and of itself reduced hepatocyte-specific functions. We identified the physiologically relevant ranges of matrix stiffness by AFM and demonstrated that primary hepatocyte functions were preserved when cultured on matrix of normal liver stiffness, but were significantly reduced when cultured on matrix with the stiffness of fibrotic liver. Importantly, we showed that the most dynamic effects of matrix rigidity on primary hepatocyte morphology and function were in the relatively narrow range between 150Pa, the stiffness of normal liver, and 1kPa, the lower threshold of fibrotic liver stiffness.
Our findings demonstrated that reduced hepatocyte functions on stiff matrix were likely in part due to reduced expression of the master transcriptional regulatory factor, HNF4α. HNF4α is critical for normal liver development (30) (31) (32) , maintaining mature liver functions (17, (33) (34) (35) , and inducing differentiation of hepatocyte-like cells from stem cells and fibroblasts (36, 37) . We confirmed previously published reports that HNF4α expression was decreased in fibrotic liver disease in vivo (38, 39) . In addition, we showed that soft matrix equivalent to normal liver stiffness preserved the HNF4α transcriptional network, whereas stiff matrix equivalent to Hepatocyte Cell Size Analysis. Isolated primary hepatocytes were plated at low density (10,000cells/18mm diameter gel) to ensure that single cells could be measured without confounding cell-to-cell contact. Phase contrast photos were taken with a Rebel T3i camera (Canon, San Jose, CA) adapted to the photoport of an Eclipse TS100 Inverted Microscope (Nikon, Melville, NY). Images were digitally acquired and processed by ImageJ software. Cell size was determined by outlining the cell membrane and calculating the surface area in pixels.
An image of a micrometer at the same magnification was used to convert pixel measurements to µm 2 .
Hepatocyte Functional Assays. Hepatocytes were plated at a density of 50,000 cells/18mm
diameter gel. For quantitative measurement of albumin production, cell culture supernatants were collected at 24h and albumin concentration was determined by a mouse albumin ELISA kit per the manufacturer's instructions (Bethyl, Montgomery, TX). Quantitative determination of glycogen storage was measured using a glycogen fluorometric assay kit per the manufacturer's instructions (Sigma). Cytochrome P450 1A activity was measured quantitatively using the luminescence-based P450-Glo Assay according to the manufacturer's instructions (Promega, Madison, Wisconsin). All functional measurements were corrected for cell number determined by the Cyquant Assay (Life Technologies, Pleasanton, CA). Cyquant was performed following the manufacturer's instructions using a standard curve generated from known numbers of primary mouse hepatocytes to convert DNA content into number of cells.
Quantitative Real-time Reverse Transcription Polymerase Chain Reaction (qRT-PCR).
Hepatocytes were plated at a density of 50,000 cells/18mm diameter gel. After 24h of culture, RNA was isolated using RNeasy Mini Kit (QIAGEN, Valencia, CA) according to the manufacturer's protocol. RNA purity was verified by the NanoDrop1000 spectrophotometer 
